Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $925.95M | $928.74M | -0.30% |
Gross Profit | $548.13M | $546.57M | +0.29% |
Net Income | $177.51M | $188.43M | -5.79% |
EPS (Basic) | $8.28 | $8.53 | -2.93% |
EPS (Diluted) | $8.24 | $8.47 | -2.72% |
R&D Expense | $46.41M | $45.48M | +2.06% |
SG&A Expense | $234.39M | $234.64M | -0.11% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.28B | $3.41B | -3.72% |
Current Assets | $1.21B | $1.29B | -5.88% |
Total Liabilities | $3.44B | $3.43B | +0.22% |
Current Liabilities | $1.13B | $1B | +12.71% |
Stockholders' Equity | $-158.72M | $-24.47M | -548.65% |
Long-Term Debt | $1.9B | $2.02B | -5.57% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $189.99M | $153.26M | +23.96% |
Investing Cash Flow | $-8.94M | $-22.39M | +60.09% |
Financing Cash Flow | $-179.09M | $-137.63M | -30.12% |
Share Buybacks | $212.5M | $250M | -15.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 59.2% | 58.9% | +0.35% |
Net Margin | 19.2% | — | — |
ROE | -111.8% | — | — |
ROA | 5.4% | — | — |
Current Ratio | $1.07 | — | — |
Debt to Equity | $-21.685 | — | — |
Other companies in Life Sciences Tools & Services